Mengenal Kanker Pankreas : Terobosan Baru dalam Diagnosis dan Pengobatan

Abel, E. V., Kim, E. J., Wu, J., Hynes, M., Bednar, F., Proctor, E., et al. (2014). The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. PloS one, 9(3), e91983. [https://doi.org/10.1371/journal.pone.0091983]

Al-Hussein, A. B. A., Tahir, F. R., & Pham, V. T. (2021). Fixed-time synergetic control for chaos suppression in endocrine glucose-insulin regulatory system. Control Engineering Practice, 108, 104723. [https://doi.org/10.1016/j.conengprac.2020.104723]

Atwood, C. (Ed.). (2011). Embryonic stem cells: Recent advances in pluripotent stem cell-based regenerative medicine. InTech. [https://doi.org/10.5772/2150]

Beatty, G. L., Werba, G., Lyssiotis, C. A., & Simeone, D. M. (2021). The biological underpinnings of therapeutic resistance in pancreatic cancer. Genes & Development, 35(13-14), 940 962.Boxhoorn, et al. "Acute Pancreatitis." The Lancet, 396: 726-734. 2020. [https://doi.org/10.1101/gad.348523.121]

Brenda, A. B. (2024). Advances in targeted therapy for cancer: Precision medicine approaches. IDOSR Journal of Applied Sciences, 9(2), 63-67. [https://doi.org/10.59298/IDOSRJAS/2024/9.2.636700]

Bai, X., Han, J., Ma, Y., & Zhang, W. (2022). ESG performance, institutional investors' preference and financing constraints: Empirical evidence from China. Borsa Istanbul Review, 22, S157-S168. [https://doi.org/10.1016/j.bir.2022.11.013]

Budhbaware, T., Rathored, J., & Shende, S. (2024). Molecular methods in cancer diagnostics: a short review. Annals of Medicine, 56(1), 2353893. [https://doi.org/10.1080/07853890.2024.2353893]

Chen, X., Wu, W., Wei, W., & Zou, L. (2022). Immune checkpoint inhibitors in peripheral T-cell lymphoma. Frontiers in Pharmacology, 13, 869488. [https://doi.org/10.3389/fphar.2022.869488]

Cocco, E., Scaltriti, M., & Drilon, A. (2018). NTRK fusion-positive cancers and TRK inhibitor therapy. Nature reviews Clinical oncology, 15(12), 731-747. [https://doi.org/10.1038/s41571-018-0113-0]

Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., et al. (2017). Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proceedings of the National Academy of Sciences, 114(38), 10202-10207. [https://doi.org/10.1073/pnas.1704961114]

Cui, J., Jiang, W., Wang, S., Wang, L., & Xie, K. (2012). Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer. Current pharmaceutical design, 18(17), 2464-2471. [https://doi.org/10.2174/13816128112092464]

Dall'Ora, M., Rovesti, G., Bonetti, L. R., Casari, G., Banchelli, F., Fabbiani, et al. (2021). TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma. American Journal of Cancer Research, 11(9), 4500. [https://pmc.ncbi.nlm.nih.gov/articles/PMC8493377/]

Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012). The pancreas cancer microenvironment. Clinical cancer research, 18(16), 4266-4276. [https://doi.org/10.1158/1078-0432.CCR-11-3114]

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). "Global Cancer Observatory: Cancer Today. 2022" Lyon, France: International Agency for Research on Cancer. [https://www.spandidos-publications.com/10.3892/ol.2024.14673]

Goonetilleke, K. S., & Siriwardena, A. K. (2007). Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO), 33(3), 266-270. [https://doi.org/10.1016/j.ejso.2006.10.004]

Goral, V. (2015). Pancreatic cancer: pathogenesis and diagnosis. Asian Pacific journal of cancer prevention, 16(14), 5619-5624. [https://doi.org/10.7314/APJCP.2015.16.14.5619]

Gu, X., & Minko, T. (2024). Targeted nanoparticle-based diagnostic and treatment options for pancreatic cancer. Cancers, 16(8), 1589. [https://doi.org/10.3390/cancers16081589]

Gupta, M., Sherrow, C., Krone, M. E., Blais, E. M., Pishvaian, M. J., Petricoin, E. F., et al. (2021). Targeting the NTRK fusion gene in pancreatic acinar cell carcinoma: a case report and review of the literature. Journal of the National Comprehensive Cancer Network, 19(1), 10-15. [https://doi.org/10.6004/jnccn.2020.7641]

Hahn, M. A., Singh, A. K., Sharma, P., Brown, S. C., & Moudgil, B. M. (2011). Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Analytical and bioanalytical chemistry, 399, 3-27. [https://doi.org/10.1007/s00216-010-4207-5]

Huang, B., Huang, H., Zhang, S., Zhang, D., Shi, Q., Liu, J., & Guo, J. (2022). Artificial intelligence in pancreatic cancer. Theranostics, 12(16), 6931. [https://doi.org/10.7150/thno.77949]

Huang, J., Lok, V., Ngai, C. H., Zhang, L., Yuan, J., Lao, X. Q., et al. (2021). Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology, 160(3), 744-754. [https://doi.org/10.1053/j.gastro.2020.10.007]

Gong, R., & Jiang, Y. (2020). Non-coding RNAs in Pancreatic Ductal Adenocarcinoma. Frontiers in oncology, 10, 309. [https://doi.org/10.3389/fonc.2020.00309]

Jaworski, J. J., Morgan, R. D., & Sivakumar, S. (2020). Circulating cell-free tumour DNA for early detection of pancreatic cancer. Cancers, 12(12), 3704. [https://doi.org/10.3390/cancers12123704]

Li, J. J., Zhu, M., Kashyap, P. C., Chia, N., Tran, N. H., McWilliams, R. R., et al. (2021). The role of microbiome in pancreatic cancer. Cancer and Metastasis Reviews, 40, 777-789. [https://doi.org/10.1007/s10555-021-09982-2]

Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016). Pancreatic cancer. The Lancet, 388(10039), 73-85. [https://doi.org/10.1016/S0140-6736(16)00141-0]

Kim, V. M., & Ahuja, N. (2015). Early detection of pancreatic cancer. Chinese Journal of Cancer Research, 27(4), 321. [https://pmc.ncbi.nlm.nih.gov/articles/PMC4560741/]

Kumar, et al. "Covalently Dye-Linked, Surface-Controlled, and Bioconju Gated Organically Modified Silica Nanoparticles as Targeted Probes for Optical Imaging." ACS Nano, 2(3): 449-56. 2008. [https://doi.org/10.1021/nn700370b]

Kumar, R., Roy, I., Ohulchanskyy, T. Y., Goswami, L. N., Bonoiu, A. C., Bergey, E. J., et al. (2008). Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS nano, 2(3), 449-456. [https://doi.org/10.1021/nn700370b]

Lellouche, L., Palmieri, L. J., Dermine, S., Brezault, C., Chaussade, S., & Coriat, R. (2021). Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives. Therapeutic advances in medical oncology, 13, 17588359211018539. [https://doi.org/10.1177/17588359211018539]

Lester, L. B. (Ed.). (2005). Stem cells in endocrinology (Vol. 1). Humana Press. [https://doi.org/10.1385/1592599001]

Limijadi, E. K. S., Muniroh, M., Prajoko, Y. W., Tjandra, K. C., & Respati, D. R. P. (2024). The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic and meta-analysis. PLoS One, 19(5), e0299276. [https://doi.org/10.1371/journal.pone.0299276]

Lugo, A., Peveri, G., Bosetti, C., Bagnardi, V., Crippa, A., Orsini, N., et al. (2018) Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis. European Journal of Cancer, 104, 117-126. [https://doi.org/10.1016/j.ejca.2018.09.007]

Maharani, S. (2012). Kanker: Mengenal 13 Jenis Kanker Dan Pengobatannya. Jakarta: Kata Hati.

Mayerle, J., Heidecke, C. D., & Lerch, M. M. (2007). Diagnostik und Therapie der chronischen Pankreatitis. Gastroenterologe, 2(4), 275. [https://doi.org/10.1007/s11377-007-0095-4]

Mehta, K. Y., Wu, H. J., Menon, S. S., Fallah, Y., Zhong, X., Rizk, N., et al. (2017). Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget, 8(40), 68899. [https://doi.org/10.18632/oncotarget.20324]

Mizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020). Pancreatic cancer. The Lancet, 395(10242), 2008-2020. [https://doi.org/10.1016/S0140-6736(20)30974-0]

Momeni‐Boroujeni, A., Yousefi, E., & Somma, J. (2017). Computer‐assisted cytologic diagnosis in pancreatic FNA: an application of neural networks to image analysis. Cancer cytopathology, 125(12), 926-933. [https://doi.org/10.1002/cncy.21915]

National Cancer Institute. (2020). Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Pancreatic Cancer. National Comprehensive Cancer Network. (2025). NCCN Clinical Practice. [https://doi.org/10.32388/5OWTL5]

National Comprehensive Cancer Network. (2025). Guidelines in Oncology: Pancreatic Adenocarcinoma (Version 2.2025). [https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455]

Nishimoto, A. (2022). Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. World Journal of Gastroenterology, 28(28), 3637. [https://doi.org/10.3748/wjg.v28.i28.3637]

O'Reilly, E. M., & Abou-Alfa, G. K. (2007, August). Cytotoxic therapy for advanced pancreatic adenocarcinoma. In Seminars in oncology (Vol. 34, No. 4, pp. 347-353). WB Saunders. [https://doi.org/10.1053/j.seminoncol.2007.05.009]

Palta, M., Godfrey, D., Goodman, K. A., Hoffe, S., Dawson, L. A., Dessert, D., et al. (2019). Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline. Practical radiation oncology, 9(5), 322-332. [https://doi.org/10.1016/j.prro.2019.06.016]

Rao, C. V., & Mohammed, A. (2015). New insights into pancreatic cancer stem cells. World journal of stem cells, 7(3), 547. [https://doi.org/10.4252/wjsc.v7.i3.547]

Resovi, A., Bani, M. R., Porcu, L., Anastasia, A., Minoli, L., Allavena, P., et al. (2018). Soluble stroma‐related biomarkers of pancreatic cancer. EMBO molecular medicine, 10(8), e8741. [https://doi.org/10.15252/emmm.201708741]

Rilla, K., Mustonen, A. M., Arasu, U. T., Härkönen, K., Matilainen, J., & Nieminen, P. (2019). Extracellular vesicles are integral and functional components of the extracellular matrix. Matrix Biology, 75, 201-219. [https://doi.org/10.1016/j.matbio.2017.10.003]

Singh, V. K., Haupt, M. E., Geller, D. E., Hall, J. A., & Diez, P. M. Q. (2017). Less common etiologies of exocrine pancreatic insufficiency. World journal of gastroenterology, 23(39), 7059. [https://doi.org/10.3748/wjg.v23.i39.7059]

Suzuki, R., Kang, Y., Li, X., Roife, D., Zhang, R., Fleming, J.B. (2014). Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Research, 34(9), 4685-4692. [https://ar.iiarjournals.org/content/34/9/4685]

Tripathi, S., Tabari, A., Mansur, A., Dabbara, H., Bridge, C. P., & Daye, D. (2024). From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer. Diagnostics (Basel, Switzerland), 14(2), 174. [https://doi.org/10.3390/diagnostics14020174]

Wang, S., Zhang, K., Tan, S., Xin, J., Yuan, Q., Xu, H., et al. (2021). Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Molecular Cancer, 20, 1-10. [https://doi.org/10.1186/s12943-020-01298-z]

Wu, W., He, X., Yang, L., Wang, Q., Bian, X., Ye, J., et al. (2018). Rising trends in pancreatic cancer incidence and mortality in 2000-2014. Clinical epidemiology, 789-797. [https://doi.org/10.2147/CLEP.S160018]

Winter, J. M., Yeo, C. J., & Brody, J. R. (2013). Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. Journal of surgical oncology, 107(1), 15-22. [https://doi.org/10.1002/jso.23192]

Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022). Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology, 163(2), 386-402. [https://doi.org/10.1053/j.gastro.2022.03.056]

Yamada, T., Hasler, W. L., & Inadomi, J. M. (2005). Structural anomalies and hereditary diseases of the pancreas. Gastroenter-ology, ed. Y. Yamada (Philadelphia, PA: Lippincott Williams & Wilkins), 80-90.

Yoon, J. H., Jung, Y. J., & Moon, S. H. (2021). Immunotherapy for pancreatic cancer. World journal of clinical cases, 9(13), 2969-2982.[https://doi.org/10.12998/wjcc.v9.i13.2969]

Yuan, Q., Pan, A., Fu, Y., & Dai, Y. (2021). Anatomy and physiology of the pancreas. In Integrative pancreatic intervention therapy (pp. 3-21). Elsevier.[https://doi.org/10.1016/B978-0-12-819402-7.00001-2]

Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106(5), 1755-1761. [https://doi.org/10.1182/blood-2005-04-1496]

Zervos, E. E., Rosemurgy, A. S., Al-Saif, O., & Durkin, A. J. (2004). Surgical management of early-stage pancreatic cancer. Cancer Control, 11(1), 23-31. [https://doi.org/10.1177/107327480401100104]

Zhang, K., Liu, X., Shen, J., Li, Z., Sang, Y., Wu, X., et al. (2020). Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of COVID-19 pneumonia using computed tomography. Cell, 181(6), 1423-1433. [https://doi.org/10.1016/j.cell.2020.04.045]

Zhang, J., Shi, Z., Xu, X., Yu, Z., & Mi, J. (2019). The influence of microenvironment on tumor immunotherapy. The FEBS journal, 286(21), 4160-4175. [https://doi.org/10.1111/febs.15028]

Zhuo, Y., Yuan, R., Chai, Y. Q., & Hong, C. L. (2010). Functionalized SiO2 labeled CA19-9 antibodies: A new strategy for signal amplification of antigen-antibody sensing processes. Analyst, 135(8), 2036-2042. [https://doi.org/10.1039/c0an00022a]